CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $75,210 | +21026.4% | 62,675 | -79.4% | 0.00% | – |
| Q1 2023 | $356 | -18.2% | 304,482 | -44.8% | 0.00% | – |
| Q4 2022 | $435 | -100.0% | 551,126 | -29.8% | 0.00% | -100.0% |
| Q3 2022 | $950,000 | -40.7% | 784,780 | -54.9% | 0.00% | 0.0% |
| Q2 2022 | $1,601,000 | +435.5% | 1,740,220 | +935.1% | 0.00% | – |
| Q1 2021 | $299,000 | +2890.0% | 168,128 | +1573.4% | 0.00% | – |
| Q4 2020 | $10,000 | -84.1% | 10,047 | -49.7% | 0.00% | – |
| Q3 2017 | $63,000 | – | 19,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |